Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blinded Placebo Controlled Trial Assessing the Effect of the Oral Cannabinoid Nabilone on Pain and Quality of Life in Patients With Fibromyalgia

NCT00272207 is registered in ClinicalTrials.gov with Winnipeg Regional Health Authority as lead sponsor.

NCT NCT00272207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00272207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blinded Placebo Controlled Trial Assessing the Effect of the Oral Cannabinoid Nabilone on Pain and Quality of Life in Patients With Fibromyalgia
Lead sponsor
Winnipeg Regional Health Authority
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2007
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia